NATURE’S SUNSHINE PRODUCTS, INC. Treasury Stock Acquired, Average Cost Per Share
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Treasury Stock Acquired, Average Cost Per Share of $12.07 per share for the 3-month period ending 2015-12-31, per its 10-K filed 2016-03-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:TreasuryStockAcquiredAverageCostPerShare · last filed 2016-03-14
- NATURE’S SUNSHINE PRODUCTS, INC. treasury stock acquired, average cost per share for the quarter ending 2015-12-31 was $12.07, a 18.45% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. treasury stock acquired, average cost per share for the quarter ending 2015-09-30 was $12.64, a 18.40% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. treasury stock acquired, average cost per share for the quarter ending 2015-06-30 was $13.13.
- NATURE’S SUNSHINE PRODUCTS, INC. treasury stock acquired, average cost per share for the quarter ending 2015-03-31 was $14.06.
- NATURE’S SUNSHINE PRODUCTS, INC. treasury stock acquired, average cost per share for fiscal 2015 was $13.26, a 11.78% decline from fiscal 2014.
- NATURE’S SUNSHINE PRODUCTS, INC. treasury stock acquired, average cost per share for fiscal 2014 was $15.03, a 17.14% decline from fiscal 2013.
- NATURE’S SUNSHINE PRODUCTS, INC. treasury stock acquired, average cost per share for fiscal 2013 was $18.14.
| Period end | Treasury Stock Acquired, Average Cost Per Share 3 month | Treasury Stock Acquired, Average Cost Per Share 3 month as first filed | Treasury Stock Acquired, Average Cost Per Share 6 month | Treasury Stock Acquired, Average Cost Per Share 9 month | Treasury Stock Acquired, Average Cost Per Share 12 month |
|---|---|---|---|---|---|
| 2015-12-31 | $12.07 10-K · filed 2016-03-14 | $13.26 10-K · filed 2016-03-14 | |||
| 2015-09-30 | $12.64 10-K · filed 2016-03-14 | $13.37 10-Q · filed 2015-11-06 | |||
| 2015-06-30 | $13.13 10-K · filed 2016-03-14 | $13.77 10-Q · filed 2015-08-10 | |||
| 2015-03-31 | $14.06 10-K · filed 2016-03-14 | $14.08 10-Q · filed 2015-05-11 | |||
| 2014-12-31 | $14.80 10-K · filed 2015-03-13 | $15.03 10-K · filed 2015-03-13 | |||
| 2014-09-30 | $15.49 10-K · filed 2015-03-13 | $15.49 10-Q · filed 2014-11-06 | |||
| 2013-12-31 | $18.44 10-K · filed 2014-03-17 | $18.14 10-K · filed 2014-03-17 | |||
| 2013-09-30 | $18.06 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |